Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Jeffrey A. Cohen(Cleveland Clinic), Ludwig Kappos(University Hospital of Basel), Shreeram Aradhye, Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Ruggero Capra(Presidio Ospedaliero), Gıancarlo Comı(Casa di Cura Columbus), Tracy Stites, Jean Pelletier(Hôpital de la Timone), Hans‐Peter Hartung(The University of Sydney), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), James Jin, Stacy Wu, Bhupendra Khatri(Hope Center for Neurological Disorders), Paolo Gallo(University of Padua), Guillermo Izquierdo(Hospital Universitario Virgen Macarena), Klaus Tiel‐Wilck
Cited by 2,192
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k